Nomax Inc. is recalling 78 cartons of Dry Eye Test (fluorescein sodium) Ophthalmic Strips because the medication is subpotent, meaning it does not contain the full required amount of the active ingredient. This defect can lead to inaccurate diagnostic results during eye examinations. These 100-count sterile strip cartons were distributed nationwide across the United States. If you have this product, you should contact your healthcare provider or pharmacist for guidance on alternative products and instructions on returning the item.
A subpotent drug may not perform as intended during a clinical eye test, which could lead to an incorrect diagnosis or an incomplete assessment of a patient's dry eye condition. No injuries or adverse events have been reported to date for this specific recall.
Drug recall remedy for subpotent medication
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.